We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
601
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
-55,000
Closed -$22.1K
PLMJ
602
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
-255,100
Closed -$2.73M
SMAR
603
DELISTED
Smartsheet Inc.
SMAR
-100,080
Closed -$4.79M
CFFS
604
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
-250,108
Closed -$2.71M
AKTS
605
DELISTED
Akoustis Technologies Inc
AKTS
-1,180,000
Closed -$984K
GHIX
606
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
-1,563,175
Closed -$16.4M
SAVE
607
DELISTED
Spirit Airlines, Inc.
SAVE
-30,000
Closed -$492K
SAVE
608
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
-300,000
Closed -$885K
DCPH
609
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-120,000
Closed -$290K
FUSN
610
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-213,107
Closed -$2.05M
SCRMW
611
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
-573,164
Closed -$262K
CBAY
612
PUT
DELISTED
Cymabay Therapeutics
CBAY
-50,000
Closed -$18.8K
HCMA
613
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
-125,054
Closed -$1.4M
KRTX
614
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-106,800
Closed -$33.8M
SPLK
615
DELISTED
Splunk Inc
SPLK
-3,680,525
Closed -$561M
ROSS
616
DELISTED
Ross Acquisition Corp II
ROSS
-318,046
Closed -$3.46M
ALTUW
617
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
-231,102
Closed -$6.22K
TGVC
618
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
-156,317
Closed -$1.7M
SZZL
619
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
-159,437
Closed -$1.76M
SLACW
620
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
-128,141
Closed -$4.32K
FICVW
621
DELISTED
Frontier Investment Corp Warrants
FICVW
-32,524
Closed -$1.17K
CHEA
622
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
-307,065
Closed -$3.38M
THRX
623
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-12,517
Closed -$50.7K
IMGN
624
DELISTED
Immunogen Inc
IMGN
-1,915,452
Closed -$56.8M
MRTX
625
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-25,000
Closed -$1.88K

Similar funds

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.